These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25585874)

  • 81. Connexin expression in human acute myeloid leukemia cells: identification of patient subsets based on protein and global gene expression profiles.
    Reikvam H; Ryningen A; Sæterdal LR; Nepstad I; Foss B; Bruserud Ø
    Int J Mol Med; 2015 Mar; 35(3):645-52. PubMed ID: 25529637
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
    Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
    Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Baghdadi TA; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS
    Clin Cancer Res; 2012 Jan; 18(2):360-369. PubMed ID: 22096027
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.
    Nan FY; Gu Y; Xu ZJ; Sun GK; Zhou JD; Zhang TJ; Ma JC; Leng JY; Lin J; Qian J
    Cancer Med; 2021 Aug; 10(15):5283-5296. PubMed ID: 34227248
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
    Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
    Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
    Jongen-Lavrencic M; Sun SM; Dijkstra MK; Valk PJ; Löwenberg B
    Blood; 2008 May; 111(10):5078-85. PubMed ID: 18337557
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
    Fukuno K; Hara T; Tsurumi H; Shibata Y; Mabuchi R; Nakamura N; Kitagawa J; Shimizu M; Ito H; Saito K; Moriwaki H
    Leuk Lymphoma; 2015 May; 56(5):1398-405. PubMed ID: 25248875
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical significance of microRNA-34b expression in pediatric acute leukemia.
    Cao L; Wang N; Pan J; Hu S; Zhao W; He H; Wang Y; Gu G; Chai Y
    Mol Med Rep; 2016 Mar; 13(3):2777-84. PubMed ID: 26861642
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 92. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
    Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
    Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [LRP15 gene promoter region methylation and its expression in acute leukemia].
    Zhao Y; Dou LP; Wang QS; Lu XC; Lou FD; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):39-41. PubMed ID: 17490517
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells.
    Li N; Jia X; Wang J; Li Y; Xie S
    Mol Med Rep; 2015 Nov; 12(5):6861-6. PubMed ID: 26397212
    [TBL] [Abstract][Full Text] [Related]  

  • 95. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
    Wang XX; Zhang H; Li Y
    Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
    [TBL] [Abstract][Full Text] [Related]  

  • 97. CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
    Li M; Gao L; Li Z; Sun J; Zhang H; Duan H; Ma Y; Wang C
    Oncotarget; 2016 May; 7(21):31454-65. PubMed ID: 27129146
    [TBL] [Abstract][Full Text] [Related]  

  • 98. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
    Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
    Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
    [TBL] [Abstract][Full Text] [Related]  

  • 99. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia.
    Du Y; Lu F; Li P; Ye J; Ji M; Ma D; Ji C
    Int J Mol Sci; 2014 Sep; 15(9):17065-76. PubMed ID: 25257528
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [ID4 promoter methylation in acute myeloid leukemia].
    Xu RR; Liu F; Cui X; Zhang XW; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.